Giessen, Germany – 17 March 2026 – Green Elephant Biotech has announced the market introduction of Archimedes® One, pioneering a new category known as the Dynamic Adherent Bioreactor. This innovative…
Recent advancements at the University of Edinburgh have showcased a remarkable innovation in biotechnology, where engineered bacteria have been utilised to convert common PET plastic waste into L-DOPA, an essential…
Applied Angstrom Technology (AAT) has inaugurated a state-of-the-art research and development facility aimed at advancing semiconductor manufacturing in Singapore. Launched on March 18, the facility is designed to innovate and…
Excalipoint has successfully raised $68.7 million to further its development of T-cell engagers, a promising area in biotechnology. This funding comprises a $41 million seed round initiated at the company’s…
SCOTTSDALE, Ariz., March 18, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation ('Journey Medical' or the 'Company') (Nasdaq: DERM), a commercial-stage pharmaceutical company focused on the marketing and sale of U.S.…
Agilisium has announced a significant investment of Rs 50 crore aimed at revolutionising the life sciences sector by facilitating the operationalisation of artificial intelligence (AI) within pharmaceutical, biotech, and medical…
Photo credit: Hanna Teib for Israel Innovation Authority The Israel Innovation Authority has announced a significant investment of NIS 10 million to support the development of new training programmes aimed…
16 March 2026 The Technical University of Munich (TUM) has once again been recognised as a "University of Excellence," marking its fourth consecutive achievement in this esteemed designation. This announcement…
Credo Technology Group Holding Ltd. has announced the introduction of Cardinal, a pioneering family of 3nm low-power, highly integrated 224G/lane optical Digital Signal Processors (DSPs). This development is strategically designed…
Data Presented Across 29 Sessions Highlights Precision, Accessibility and Platform-Agnostic Adoption, Establishing pTau217 as a Leading Blood-Based Biomarker CARLSBAD, Calif., March 17, 2026 /PRNewswire/ -- ALZpath, Inc., a prominent entity…
